Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kezar Life Sciences (KZR) Revenue (2021 - 2025)

Kezar Life Sciences' Revenue history spans 5 years, with the latest figure at -$302000.0 for Q2 2025.

  • For Q2 2025, Revenue rose 24.69% year-over-year to -$302000.0; the TTM value through Sep 2025 reached -$1.0 million, down 29.59%, while the annual FY2023 figure was $7.0 million, N/A changed from the prior year.
  • Revenue for Q2 2025 was -$302000.0 at Kezar Life Sciences, up from -$347000.0 in the prior quarter.
  • Across five years, Revenue topped out at $7.0 million in Q3 2023 and bottomed at -$401000.0 in Q2 2024.
  • The 5-year median for Revenue is -$328500.0 (2022), against an average of $284250.0.
  • The largest YoY upside for Revenue was 2358.06% in 2023 against a maximum downside of 45.67% in 2023.
  • A 5-year view of Revenue shows it stood at -$159000.0 in 2021, then crashed by 94.97% to -$310000.0 in 2022, then skyrocketed by 2358.06% to $7.0 million in 2023, then crashed by 105.56% to -$389000.0 in 2024, then increased by 22.37% to -$302000.0 in 2025.
  • Per Business Quant, the three most recent readings for KZR's Revenue are -$302000.0 (Q2 2025), -$347000.0 (Q1 2025), and -$389000.0 (Q4 2024).